Skip to main content
. Author manuscript; available in PMC: 2009 Aug 25.
Published in final edited form as: Eur J Cancer. 2008 Jul 21;44(12):1684–1692. doi: 10.1016/j.ejca.2008.05.018

Table 5.

Mean (coefficient of variation) pharmacokinetic parameters for cycle 1 of R(+)XK469

Dose level N Cmax (μg/ml) AUC0→T (h μg/ml) AUC0→∞ (h μg/ml) t½ (h) Cl (ml/h) Vss (L)




Day 1 Day 3 Day 1 Day 3 Day 1 Day 3 Day 1 Day 1 Day 1
Schedule A (mg)
15 2 1.2 (0.03) 24 (0.10) 106 (0.72) 66 (0.75) 191 (0.72) 13 (0.50)
30 2 4.1 (0.29) 41 (0.18) 162 (0.30) 57 (0.11) 194 (0.30) 15 (0.19)
60 2 8.8 (0.02) 92 (0.19) 223 (0.44) 31 (0.33) 297 (0.44) 12 (0.10)
120 1 14.3 148 347 30 345 15
240 4 27.9 (0.14) 335 (0.10) 1.285 (0.54) 56 (0.60) 244 (0.64) 14 (0.16)
Schedule B (mg)
360 3 58.0 (0.31) 79.9 (0.18) 1.177 (0.14) 1.885 (0.24) 2.577 (0.25) 4.091 (0.37) 54 (0.36) 147 (0.29) 11 (0.22)
540 6 71.5 (0.20) 89.6 (0.32) 1.469 (0.20) 2.010 (0.28) 5.002 (0.77) 5.564 (0.74) 90 (0.85) 152 (0.51) 14 (0.20)
675 5 86.2 (0.18) 104.2 (0.14) 1.581 (0.12) 2.195 (0.22) 3.033 (0.18) 4.335 (0.30) 61 (0.71) 220 (0.23) 13 (0.24)
850 7 105.1 (0.17) 127.1 (0.15) 2.270 (0.24) 3.307 (0.29) 5.161 (0.59) 7.748 (0.53) 43 (0.55) 216 (0.56) 13 (0.14)
1100 20 146.3 (0.22) 166.5 (0.21) 3.067 (0.26) 4.489 (0.28) 7.903 (0.49) 10.531 (0.43) 55 (0.41) 169 (0.45) 14 (0.31)
1400 1 173.1 177.7 4.571 6.718 16.473 35.930 107 84 13
Schedule C (mg)
1600 5 172.0 (0.21) 4.607 (0.28) 13.785 (0.55) 75 (0.47) 144 (0.51) 14 (0.32)
2000 3 247.6 (0.22) 5.704 (0.12) 11.204 (0.19) 47 (0.10) 183 (0.18) 12 (0.09)
2500 14 293.9 (0.19) 7.125 (0.30) 13.905 (0.52) 42 (0.33) 215 (0.39) 11 (0.16)
3200 5a 292.3 (0.20) 8.155 (0.21) 16.445 (0.21) 49 (0.08) 193 (0.24) 13 (0.22)
a

One patient had blood levels drawn at significantly insufficient time points.